This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Are Investors Undervaluing Old Republic International (ORI) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Old Republic International (ORI) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Old Republic (ORI) delivered earnings and revenue surprises of 20.51% and 10.26%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Old Republic International (ORI) Q4 Earnings Expected to Decline
by Zacks Equity Research
Old Republic (ORI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Find Strong Stocks for 2020 with this New Analyst Coverage Screener
by Benjamin Rains
The stock market started December on shaky ground, which means it's even more important to be proactive as we approach 2020. One way to do so is to search for stocks that have recently received new analyst coverage...
New Strong Sell Stocks for November 21st
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for October 29th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Old Republic International (ORI) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Old Republic (ORI) delivered earnings and revenue surprises of 2.00% and 3.29%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Old Republic International (ORI) Q3 Earnings Expected to Decline
by Zacks Equity Research
Old Republic (ORI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Old Republic Rewards Shareholders, Okays Special Dividend
by Zacks Equity Research
Special dividend approval by the board of directors of Old Republic International (ORI) marks the company's decision to return excess capital to its shareholders.
Old Republic International (ORI) Q2 Earnings Meet Estimates
by Zacks Equity Research
Old Republic (ORI) delivered earnings and revenue surprises of 0.00% and 2.79%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Old Republic International (ORI) Q2 Earnings Expected to Decline
by Zacks Equity Research
Old Republic (ORI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Old Republic International (ORI) Q1 Earnings Expected to Decline
by Zacks Equity Research
Old Republic (ORI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Hold Old Republic International Stock
by Zacks Equity Research
Old Republic International (ORI) is poised to grow given improving real estate market fundamentals, increasing home sales and housing price inflation.
Old Republic International (ORI) Q4 Earnings & Revenues Top
by Zacks Equity Research
Old Republic International (ORI) Q4 results reflect higher net premiums earned in commercial auto and increase in investment income.
Old Republic International (ORI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Old Republic (ORI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cigna, Express Scripts Join Forces for Better Healthcare
by Zacks Equity Research
Cigna (CI) completes merger with Express Scripts. The new entity aims to provide affordable and flexible healthcare solutions to customers.
Fed Hikes Rate Fourth Time This Year: 6 Solid Insurance Picks
by Zacks Equity Research
Amid an improving macro backdrop, we focus on six stocks with strong fundamentals from the insurance industry for better returns to investors.
Hartford Financial (HIG) Introduces Insurance Product Line
by Zacks Equity Research
Hartford Financial (HIG) launches credit and political risk insurance products for conserving customer interests.
6 Solid Reasons to Invest in MetLife for Portfolio Growth
by Zacks Equity Research
Backed by a solid capital management and business rejig, MetLife (MET) holds great prospects to reap returns for investors.
Why Old Republic International (ORI) is Such a Great Value Stock Pick Right Now
by Zacks Equity Research
Old Republic International (ORI) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
Forget AIG, Buy These Insurance Stocks Instead
by Sapna Bagaria
While the stock of AIG is weighed down by the company's headwinds, other stocks in the industry look attractive.
6 Solid Reasons to Hold Aon (AON) Stock in Your Portfolio
by Zacks Equity Research
Banking on solid results, strategic initiatives and a strong financial position, Aon (AON) promises to reap favorable returns for investors.
7 Solid Reasons Why Cigna is a Must Add to Your Portfolio
by Zacks Equity Research
Backed by a solid third-quarter performance, strong Global Healthcare segment and burgeoning membership, Cigna (CI) holds great potential for yield-seeking investors.
Old Republic International (ORI) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Old Republic (ORI) delivered earnings and revenue surprises of 27.27% and 5.12%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Old Republic International (ORI) Q3 Earnings Preview: Here's What to Look Out For
by Zacks Equity Research
Old Republic (ORI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.